Aptevo Therapeutics Inc. (APVO) News
Track canonical SquawkNews coverage tagged to APVO, Aptevo Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
APVO Raises $4.5 Million
Aptevo Therapeutics announces exercise of existing warrants and PIPE for $4.5 million gross proceeds
EQUITY | Aug 12, 2026, 01:33 PM UTC
L
APVO Aptevo Therapeutics - announces new solid tumor strategy - SEC filing - Files patent application for nectin-4 X pd-l1 dual-targeting ba
APVO Aptevo Therapeutics - announces new solid tumor strategy - SEC filing - Files patent application for nectin-4 X pd-l1 dual-targeting backbone - SEC filing
REGULATION | Jul 27, 2026, 08:14 PM UTC
H
Why Ultra Clean Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Shares of Ultra Clean Holdings Inc (NASDAQ: UCTT ) rose sharply in pre-market trading after the company announced the appointment of Michael Keogh as CFO. The company appoints Michael Keogh as CFO, effective Aug. 25, suc
EARNINGS | Jul 09, 2026, 08:53 AM UTC
L
Andy Hill Cancer Research Endowment Awards Aptevo Therapeutics $1.5M Non-Dilutive Research Grant For APVO451.
Andy Hill Cancer Research Endowment Awards Aptevo Therapeutics $1.5M Non-Dilutive Research Grant For APVO451.
EQUITY | Jun 30, 2026, 12:15 PM UTC